Navigation Links
Replidyne in Medical News

Replidyne Announces Restructuring of Operations

...t by approximately 80% to 5 employees in actions that are scheduled to take place during September 2008 and October 2008. As a result of these actions replidyne will suspend further development activities of REP3123, its investigational agent for the treatment of Clostridium difficile (C. difficile) bacteria a...

Replidyne Pipeline Featured at 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy

... 1 Oral Session and 21 Poster Sessions ~ ~ replidyne Debuts New Clostridium difficile Program ~ LOUIS...pment organization," commented Kenneth J. Collins, replidyne President and CEO. "In particular, we will be pres... are essential for normal intestinal functioning. replidyne will present the following C. difficile posters on...

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

...ed with low systemic exposure, or drug absorption into the bloodstream, which is desirable for a topical antibiotic treatment. Based on these results, replidyne plans to initiate Phase II trials in children with impetigo, the most common bacterial skin infection, by the end of the year. "REP8839 is a p...
Replidyne in Medical Technology

Replidyne Discontinues Phase III Trial

...h acute exacerbation of chronic bronchitis (AECB). replidyne took this action to conserve its cash assets and s...hree adult community respiratory tract infections. replidyne has not initiated the other three trials, and cons...ance, further faropenem development will depend on replidyne securing a partner for the program. "In the inte...

Replidyne Provides Strategic Update

... with its strategic and operations priorities, replidyne has reduced headcount by approximately 35 perc... and commercial functions. -- Pipeline programs. replidyne will retain key research and development exper...lt of prioritizing these preclinical programs, replidyne has suspended the development of topical antibioti...

Replidyne to Participate on Anti-infective Panel at RBC Capital Markets Healthcare Conference

... website after the event for a period of 30 days. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discovering, developing, in-licen...-positive C. difficile bacteria and C. difficile-associated disease (CDAD). replidyne is pursuing the development of other novel anti-infective programs based on...

Replidyne's Investigational Antibacterial Agent REP3123 Prevents Toxin Production in Clostridium difficile

...hsner, Ph.D., Principal Scientist, Microbiology at replidyne during poster session 229 titled, "New Agents Acti...s novel treatment options. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...uction and spore-forming in C. difficile bacteria. replidyne is also pursuing the development of other novel an...

Replidyne's Investigational Antibacterial Agent REP3123 Prevents Sporulation in Clostridium difficile

...tchley, Ph.D., Executive Director, Microbiology at replidyne during poster session 229 titled, "New Agents Acti...s novel treatment options. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...uction and spore-forming in C. difficile bacteria. replidyne is also pursuing the development of other novel an...

Replidyne Phase II Pediatric Trial Meets Primary Objective

...iatric antibiotic prescriptions for this illness. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discovering, developing, in-licen...nd infections, including methicillin resistant S. aureus (MRSA) infections. replidyne is also pursuing the development of other novel anti-infective products bas...

Replidyne Announces Positive Phase I Results for Topical Antibiotic REP8839

...ical antibiotic treatment. Based on these results, replidyne plans to initiate Phase II trials in children with...all impetigo treatments. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...methicillin-resistant S. aureus (MRSA) infections. replidyne is also pursuing the development of other novel an...
Replidyne in Biological Technology

Replidyne and Cardiovascular Systems Sign Merger Agreement

...e merger agreement under which CSI will merge with replidyne in an all-stock transaction. Under terms of the agreement, replidyne will issue new shares of its common stock to CSI s...ted to own 83 percent of the combined company, and replidyne shareholders are expected to own 17 percent of the...

Replidyne Announces Second Quarter 2008 Results From Operations

...cond quarter and six months ended June 30, 2008. replidyne reported a net loss of $18.7 million for the quart...basis, for the second quarter ended June 30, 2007. replidyne reported a net loss of $27.7 million for the six m...ves process." During the second quarter of 2008, replidyne announced that it had decided to terminate its lic...

Replidyne Terminates Faropenem Agreements

...or the faropenem program. As previously announced, replidyne had discontinued clinical development of faropenem...lication inhibition technology." At May 31, 2008 replidyne had cash and short term investments totaling $71.5 million. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...

Replidyne to Report First Quarter 2008 Earnings

...earnings. On Thursday, May 8, 2008 at 4:00 P.M. ET replidyne will host its annual shareholder meeting at Compan...tp://www.Replidyne.com . About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...fficile bacteria and C. difficile Infection (CDI). replidyne is pursuing the development of other novel anti-in...

Replidyne Announces 2007 Fourth Quarter and Full Year Results

...h quarter and full year ended December 31, 2007. replidyne reported a net loss of $16.9 million for the fourt...er 31, 2006. For the year ended December 31, 2007, replidyne reported net income of $7.7 million, or $0.29 per ...gnized as revenue in the period ended May 7, 2007. replidyne will not report any revenue under this agreement f...

Replidyne to Report 2007 Fourth Quarter and Year-End Earnings

...ourth quarter and year-end earnings. Additionally, replidyne will present at an upcoming investor conference in...ry 13, 2008 at 9:30 A.M. About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discover...cteria and C. difficile-associated disease (CDAD). replidyne is pursuing the development of other novel anti-in...

Replidyne to Announce Third Quarter 2007 Earnings

...he company's website at http://www.Replidyne.com . About Replidyne, Inc. replidyne is a biopharmaceutical company focused on discovering, developing, in-licen...-positive C. difficile bacteria and C. difficile-associated disease (CDAD). replidyne is pursuing the development of other novel anti-infective programs based on...
Other Tags
(Date:8/20/2014)... Low market concentration, low price volatility, high ... the market for packaging design services. These factors foster ... indicating a moderate level of buyer power. “This level ... equal amount of leverage during negotiations,” according to IBISWorld ... exist for packaging design services . Buyers need ...
(Date:8/20/2014)... August 20, 2014 First Choice ... emergency rooms in the United States, named Richard Daniels, ... FM 685 facility. , “We are pleased to ... director of our second facility in Pflugerville,” said Dr. ... Emergency Room. , Dr. Daniels received his undergraduate ...
(Date:8/20/2014)... CA (PRWEB) August 20, 2014 Kowa ... Expo West show to debut the new SL-17 portable ... a 20,000 lux white LED source controlled by an ... examination rooms. The SL-17 uses commercially available AAA rechargeable ... the previous SL-15 design requiring batteries designed specifically for ...
(Date:8/20/2014)... 20, 2014 This agreement will ... software defined networking, high availability cloud enablement, service, ... Resellers, while allowing OPEN-V to sell storageFOUNDRY’s expanding ... to work with OPEN-V on this distribution agreement ... manager distribution channels at storageFOUNDRY. "Nautilus is a ...
(Date:8/19/2014)... in Houston, Texas, is pleased to announce it is now ... with old fillings that need replacing, will benefit from the ... teeth. , From now on any cavities will be repaired ... amalgam free. Even though amalgam fillings have been deemed as ... children over the age of six, they do contain mercury ...
Breaking Medicine News(10 mins):Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Packaging Design Services Procurement Category Market Research Report Now Available from IBISWorld 4Health News:First Choice Emergency Room Announces Dr. Richard Daniels as Medical Director of the Pflugerville – FM 685 Facility 2Health News:Kowa Optimed (Booth MS13043) to Debut New Portable Slit Lamp at 2014 Vision Expo West in Las Vegas, Nevada 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 2Health News:storageFOUNDRY and Open-V OzoneStack Announce Bilateral Distribution Agreement 3Health News:Midtown Dentistry Announces It Is Now an Amalgam-Free Office 2
(Date:8/19/2014)... crocodiles colonised the seas during warm phases and became ... study which establishes a link between marine crocodilian diversity ... of more than 140 million years. , The ... de Lyon, France and formerly from the University of ... Communications ., Today, crocodiles are ,cold-blooded, animals that mainly ...
(Date:8/19/2014)... The University of Texas Health Science Center at San ... (UTSA) today announced the awarding of more than $750,000 ... (SALSI) Innovation Challenge. , Launched in 2003, SALSI is ... and an academic health science center join forces for ... funds collaborative studies, with a focus on public health ...
(Date:8/19/2014)... has been awarded a nearly $40,000 grant from the ... office of the National Park Service (NPS) and U.S. ... one-year study of the energy efficiency and cost effectiveness ... humid climates. , Radiant barriers are reflective thermal insulations ... back, thereby reducing the amount of heat emitted in ...
Breaking Biology News(10 mins):Evolution of marine crocodilians constrained by ocean temperatures 2San Antonio Life Sciences Institute awards $750,000 to innovators 2San Antonio Life Sciences Institute awards $750,000 to innovators 3UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 2UTSA researcher awarded $38K+ to evaluate energy efficiency options for historic homes 3
Other Contents